IN2015DE05009A - - Google Patents
Info
- Publication number
- IN2015DE05009A IN2015DE05009A IN5009DE2015A IN2015DE05009A IN 2015DE05009 A IN2015DE05009 A IN 2015DE05009A IN 5009DE2015 A IN5009DE2015 A IN 5009DE2015A IN 2015DE05009 A IN2015DE05009 A IN 2015DE05009A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B20/00—Preservation of edible oils or fats
- A23B20/30—Preservation of other edible oils or fats, e.g. shortenings or cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0007—Organic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261734331P | 2012-12-06 | 2012-12-06 | |
| US201361780948P | 2013-03-13 | 2013-03-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DE05009A true IN2015DE05009A (https=) | 2015-12-18 |
Family
ID=50884050
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1505MU2015 IN2015MU01505A (https=) | 2012-12-06 | 2015-06-10 | |
| IN5009DE2015 IN2015DE05009A (https=) | 2012-12-06 | 2015-06-10 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1505MU2015 IN2015MU01505A (https=) | 2012-12-06 | 2015-06-10 |
Country Status (9)
| Country | Link |
|---|---|
| EP (3) | EP2929041A4 (https=) |
| JP (4) | JP2016501249A (https=) |
| KR (3) | KR20210059779A (https=) |
| CN (4) | CN104902888A (https=) |
| AU (7) | AU2013354979A1 (https=) |
| CA (2) | CA2894366A1 (https=) |
| IN (2) | IN2015MU01505A (https=) |
| MX (2) | MX2015007082A (https=) |
| WO (2) | WO2014089511A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101568665B1 (ko) | 2015-07-21 | 2015-11-12 | 디와이오토 주식회사 | 모터의 맥동 전류를 증가시키는 브러시 구조 |
| WO2018001844A1 (en) * | 2016-06-28 | 2018-01-04 | Nestec S.A. | Biomarkers of blood-brain barrier dysfunction |
| JP2018168139A (ja) * | 2016-10-21 | 2018-11-01 | マルハニチロ株式会社 | ｎ−３系不飽和脂肪酸を含む中性脂肪値の低減または上昇抑制用の組成物、並びに該組成物の製造におけるｎ−３系不飽和脂肪酸の使用 |
| JP7099821B2 (ja) * | 2017-12-20 | 2022-07-12 | ポッカサッポロフード＆ビバレッジ株式会社 | Ｐｃｓｋ９阻害剤及びコレステロール代謝改善用食品組成物 |
| EP3586640A1 (en) | 2018-06-21 | 2020-01-01 | Nuseed Pty Ltd | Dha enriched polyunsaturated fatty acid compositions |
| EP3586642A1 (en) | 2018-06-21 | 2020-01-01 | Nuseed Pty Ltd | Ala enriched polyunsaturated fatty acid compositions |
| EP3586641A1 (en) | 2018-06-21 | 2020-01-01 | Nuseed Pty Ltd | Dha enriched polyunsaturated fatty acid compositions |
| EP3586643A1 (en) | 2018-06-21 | 2020-01-01 | Nuseed Pty Ltd | Dha enriched polyunsaturated fatty acid compositions |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| GB9901809D0 (en) * | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
| GB0016045D0 (en) | 2000-06-29 | 2000-08-23 | Laxdale Limited | Therapeutic combinations of fatty acids |
| JP2002125618A (ja) * | 2000-10-30 | 2002-05-08 | Katsuyuki Wakatsuki | 健康食品 |
| EP1714564A1 (en) * | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Method for treatment and prevention of respiratory insufficiency |
| WO2007058523A1 (en) | 2005-11-17 | 2007-05-24 | N.V. Nutricia | Composition with docosapentaenoic acid |
| NZ573719A (en) * | 2006-07-05 | 2011-08-26 | Photonz Corp Ltd | Production of ultrapure eicosapentaenoic acid and polar lipids from largely heterotrophic culture of nitzschia laevis |
| KR100684642B1 (ko) * | 2006-09-14 | 2007-02-22 | 주식회사 일신웰스 | 어유 유래 글리세라이드 유지 조성물 및 이의 제조방법 |
| WO2010119319A1 (en) * | 2009-03-09 | 2010-10-21 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof |
| US20110071090A1 (en) * | 2009-03-11 | 2011-03-24 | Stable Solutions Llc | Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle |
| US8241672B2 (en) * | 2009-03-11 | 2012-08-14 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| SG10201605794PA (en) | 2009-04-29 | 2016-09-29 | Amarin Pharmaceuticals Ie Ltd | Stable Pharmaceutical Composition And Methods Of Using Same |
| EP3318255B1 (en) * | 2009-06-15 | 2021-03-10 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating stroke in a subject on concomitant statin therapy |
| WO2012112511A1 (en) * | 2011-02-16 | 2012-08-23 | Pivotal Therapeutics, Inc. | Cholesterol absorption inhibitor (azetidinone) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events |
| EP2675445A1 (en) * | 2011-02-16 | 2013-12-25 | Pivotal Therapeutics, Inc. | Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases |
| WO2013192109A1 (en) * | 2012-06-17 | 2013-12-27 | Matinas Biopharma, Inc. | Omega-3 pentaenoic acid compositions and methods of use |
-
2013
- 2013-12-06 AU AU2013354979A patent/AU2013354979A1/en not_active Abandoned
- 2013-12-06 EP EP13861394.8A patent/EP2929041A4/en not_active Withdrawn
- 2013-12-06 JP JP2015545896A patent/JP2016501249A/ja active Pending
- 2013-12-06 MX MX2015007082A patent/MX2015007082A/es unknown
- 2013-12-06 KR KR1020217013255A patent/KR20210059779A/ko not_active Abandoned
- 2013-12-06 CN CN201380064003.5A patent/CN104902888A/zh active Pending
- 2013-12-06 JP JP2015545894A patent/JP6881893B2/ja not_active Expired - Fee Related
- 2013-12-06 EP EP21170003.4A patent/EP3888646A1/en not_active Withdrawn
- 2013-12-06 EP EP13861305.4A patent/EP2928462A4/en not_active Withdrawn
- 2013-12-06 MX MX2015007085A patent/MX2015007085A/es unknown
- 2013-12-06 KR KR1020157016331A patent/KR20150103671A/ko not_active Ceased
- 2013-12-06 CA CA2894366A patent/CA2894366A1/en not_active Abandoned
- 2013-12-06 CN CN201380063980.3A patent/CN104937103A/zh active Pending
- 2013-12-06 WO PCT/US2013/073714 patent/WO2014089511A2/en not_active Ceased
- 2013-12-06 CA CA2894183A patent/CA2894183A1/en not_active Abandoned
- 2013-12-06 CN CN202010984870.2A patent/CN112107570A/zh active Pending
- 2013-12-06 CN CN202110585483.6A patent/CN113274378A/zh active Pending
- 2013-12-06 KR KR1020157017202A patent/KR20150103009A/ko not_active Ceased
- 2013-12-06 AU AU2013354969A patent/AU2013354969A1/en not_active Abandoned
- 2013-12-06 WO PCT/US2013/073701 patent/WO2014089501A1/en not_active Ceased
-
2015
- 2015-06-10 IN IN1505MU2015 patent/IN2015MU01505A/xx unknown
- 2015-06-10 IN IN5009DE2015 patent/IN2015DE05009A/xx unknown
-
2017
- 2017-09-22 AU AU2017232203A patent/AU2017232203A1/en not_active Abandoned
-
2018
- 2018-09-12 AU AU2018229440A patent/AU2018229440A1/en not_active Abandoned
-
2019
- 2019-06-20 JP JP2019114492A patent/JP2019172697A/ja active Pending
- 2019-08-14 AU AU2019216634A patent/AU2019216634A1/en not_active Abandoned
-
2020
- 2020-06-03 AU AU2020203658A patent/AU2020203658A1/en not_active Abandoned
-
2021
- 2021-03-24 AU AU2021201865A patent/AU2021201865A1/en not_active Abandoned
- 2021-05-19 JP JP2021084578A patent/JP2021120407A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014089511A3 (en) | 2014-07-31 |
| EP2929041A1 (en) | 2015-10-14 |
| JP6881893B2 (ja) | 2021-06-02 |
| CN104902888A (zh) | 2015-09-09 |
| CN113274378A (zh) | 2021-08-20 |
| JP2016501248A (ja) | 2016-01-18 |
| JP2019172697A (ja) | 2019-10-10 |
| JP2016501249A (ja) | 2016-01-18 |
| MX2015007082A (es) | 2016-01-12 |
| JP2021120407A (ja) | 2021-08-19 |
| AU2017232203A1 (en) | 2017-10-12 |
| EP2928462A2 (en) | 2015-10-14 |
| EP3888646A1 (en) | 2021-10-06 |
| CN112107570A (zh) | 2020-12-22 |
| AU2013354979A1 (en) | 2015-06-11 |
| CN104937103A (zh) | 2015-09-23 |
| CA2894183A1 (en) | 2014-06-12 |
| EP2928462A4 (en) | 2016-06-01 |
| KR20150103671A (ko) | 2015-09-11 |
| AU2019216634A1 (en) | 2019-09-05 |
| WO2014089511A2 (en) | 2014-06-12 |
| WO2014089501A1 (en) | 2014-06-12 |
| AU2018229440A1 (en) | 2018-10-04 |
| IN2015MU01505A (https=) | 2016-05-27 |
| MX2015007085A (es) | 2016-01-12 |
| KR20210059779A (ko) | 2021-05-25 |
| AU2020203658A1 (en) | 2020-06-25 |
| AU2013354969A1 (en) | 2015-06-11 |
| KR20150103009A (ko) | 2015-09-09 |
| AU2021201865A1 (en) | 2021-04-22 |
| CA2894366A1 (en) | 2014-06-12 |
| EP2929041A4 (en) | 2016-06-08 |